VTE Prophylaxis After Discharge for Critical Illness Myopathy
Extended-duration VTE prophylaxis is NOT recommended after hospital discharge for patients with critical illness myopathy. 1
Key Guideline Recommendations
The American Society of Hematology (ASH) 2018 guidelines provide clear, strong recommendations against extending VTE prophylaxis beyond hospitalization:
In critically ill medical patients, inpatient VTE prophylaxis is recommended OVER inpatient plus extended-duration outpatient prophylaxis (strong recommendation, moderate certainty in evidence). 1
This strong recommendation applies to all critically ill medical patients, which includes those with critical illness myopathy, as they fall within the critically ill medical patient population. 1
The guideline explicitly states to use prophylaxis during hospitalization only and recommends against extending pharmacological prophylaxis after hospital discharge. 1
During Hospitalization
While hospitalized, patients with critical illness myopathy should receive appropriate VTE prophylaxis:
Pharmacological prophylaxis with UFH or LMWH is strongly recommended during the acute critical illness phase (strong recommendation, moderate certainty). 1
LMWH is conditionally preferred over UFH (conditional recommendation, moderate certainty). 1
Prophylaxis should continue throughout the hospitalization period as long as VTE risk factors persist and bleeding risk remains acceptable. 1
Important Clinical Context
Critical illness myopathy patients face competing risks:
While immobilization from muscle weakness increases VTE risk, the evidence does not support extending prophylaxis post-discharge even in this high-risk population. 1
The ASH guidelines prioritized mortality, pulmonary embolism, DVT, and major bleeding as critical outcomes—extended prophylaxis did not improve these outcomes sufficiently to justify the bleeding risk. 1
Research shows that VTE events do occur after ICU discharge (5.7% of ICU survivors in one study), but prophylaxis rates drop significantly after ward transfer (from 87.6% to 59.8%). 2 However, this observation has not translated into guideline support for extended prophylaxis.
Common Pitfall to Avoid
Do not confuse surgical patients with medical patients. Extended prophylaxis may be appropriate for certain surgical populations (e.g., orthopedic surgery), but the strong recommendation against extended prophylaxis specifically applies to critically ill medical patients, including those with critical illness myopathy. 1
The 2012 CHEST guidelines similarly recommended against extending thromboprophylaxis beyond the hospitalization period for acutely ill medical patients. 1